Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Spring Sale
Enjoy this offer
* See conditions under "Our services"

Valuation: Yield10 Bioscience, Inc.

Capitalization 2L 2L 2L 2L 3L 2.11Cr 3L 21.13L 8L 1.01Cr 9L 8L 3.64Cr P/E ratio 2022
-0.6x
P/E ratio 2023 -0.13x
Enterprise value 23.39L 20.21L 18.25L 17.45L 31.81L 22Cr 32.71L 2.16Cr 85.98L 10Cr 87.77L 85.92L 37Cr EV / Sales 2022
14.6x
EV / Sales 2023 83x
Free-Float
85.78%
Yield 2022 *
-
Yield 2023 -
1 month 0
Extreme 0.0001
0
Current year 0
Extreme 0
0
1 year 0
Extreme 0
0.02
3 years 0
Extreme 0
78.96
5 years 0
Extreme 0
410.4
10 years 0
Extreme 0
21,599.97
Manager TitleAgeSince
Chief Executive Officer 68 17/10/2016
Director of Finance/CFO 70 03/11/2014
Director TitleAgeSince
Director/Board Member 68 07/07/2009
Chairman 69 08/11/2011
Director/Board Member 63 02/03/2017
Change 5d. change 1-year change 3-years change Capi.($)
-.--%-.--%-99.33%-100.00% 73
-0.03%-4.90%-9.24%-6.96% 4.41TCr
-3.58%-1.24%+15.80%+30.18% 3.32TCr
+1.46%+5.88%+18.52%+47.53% 3.1TCr
-0.91%-4.11%-7.69%-13.60% 2.88TCr
-1.85%-2.53%+147.76%+330.12% 1.97TCr
+1.49%-3.30%+52.70%+113.21% 1.4TCr
-1.34%-0.30%+44.03%+168.46% 1.36TCr
-1.17%-4.78%+24.94%-0.89% 1.29TCr
-1.10%-1.72%+121.10%+119.98% 1.24TCr
Average -0.66%-2.77%+30.86%+68.80% 2.09TCr
Weighted average by Cap. -0.72%-3.16%+31.19%+65.04%

Financials

2022 2023
Net sales 4L 4L 4L 3L 6L 4.15Cr 6L 41.5L 16.54L 1.98Cr 16.88L 16.53L 7.15Cr 60T 51.85T 46.81T 44.76T 81.6T 55.33L 83.89T 6L 2L 26.46L 2L 2L 95.29L
Net income -1.36Cr -1.17Cr -1.06Cr -1.01Cr -1.84Cr -125.1Cr -1.9Cr -13Cr -4.99Cr -60Cr -5.09Cr -4.98Cr -215.46Cr -1.45Cr -1.25Cr -1.13Cr -1.08Cr -1.97Cr -133.3Cr -2.02Cr -13Cr -5.31Cr -64Cr -5.42Cr -5.31Cr -229.58Cr
Net Debt -16.97L -14.66L -13.24L -12.66L -23.08L -16Cr -23.73L -1.56Cr -62.38L -7.48Cr -63.67L -62.33L -27Cr 21.1L 18.23L 16.46L 15.74L 28.69L 19Cr 29.5L 1.95Cr 77.56L 9.3Cr 79.17L 77.5L 34Cr
Logo Yield10 Bioscience, Inc.
Yield10 Bioscience, Inc. is an agricultural bioscience company that is leveraging advanced genetics to develop the oilseed Camelina sativa (Camelina) as a platform crop for large-scale production of sustainable seed products. These seed products include feedstock oils for renewable diesel and sustainable aviation biofuels; omega-3 (EPA and DHA+EPA) oils for pharmaceutical, nutraceutical and aquafeed applications; and PHA bioplastics for use as biodegradable bioplastics. The Company is pursuing Camelina seed oil products for two market opportunities and value chains. The first product is seed oil produced by Camelina, which is genetically engineered to enable production of high levels of the omega-3 fatty acids eicosapentanoic acid (EPA) and docosahexanoic acid (DHA). The second product is Camelina seed oil for use as a low-carbon intensity feedstock oil for biofuels, including biodiesel, renewable diesel (RD) and sustainable aviation fuel (SAF).
Employees
29
Date Price Change Volume

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. YTEN.Q Stock
SPRING SALE -40%: The Best Tools Reserved for Subscribers to Identify Tomorrow's Top Investments!
d
:
:
BENEFIT NOW